These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1621753)

  • 1. Antibiotic therapy for urinary tract infections.
    Iravani A; Bischoff W
    Am J Med; 1992 Jun; 92(6A):95S-100S. PubMed ID: 1621753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL; Bischoff W
    Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
    Iravani A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):750-2. PubMed ID: 2069382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loracarbef vs. cefaclor in pediatric skin and skin structure infections.
    Hanfling MJ; Hausinger SA; Squires J
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S27-30. PubMed ID: 1513609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
    Iravani A; Doyle CA; Durham SJ; Wilber RB
    Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute bronchitis: results of U.S. and European trials of antibiotic therapy.
    Dere WH
    Am J Med; 1992 Jun; 92(6A):53S-57S. PubMed ID: 1621745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP; Nemeth MA; Keyserling CH; Hotary LH; Tack KJ
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population.
    McCarty J
    Am J Med; 1992 Jun; 92(6A):74S-79S. PubMed ID: 1621750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis.
    Zeckel ML; Johns D; Masica DN; Farlow D
    Clin Ther; 1995; 17(2):214-30. PubMed ID: 7614522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative United States and European trials of loracarbef in the treatment of acute otitis media.
    Foshee WS; Qvarnberg Y
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S12-9. PubMed ID: 1513607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
    Zeckel ML
    Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
    McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
    Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
    Christenson JC; Gooch WM; Herrod JN; Swenson E
    J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.
    Müller O; Wettich K
    Infection; 1992; 20(3):176-82. PubMed ID: 1463527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily dosing of loracarbef 15 mg/kg versus 30 mg/kg in the treatment of children with acute sinusitis.
    Balatsouras DG; Korres S; Rallis E; Eliopoulos P; Ferekidis E
    Drugs Exp Clin Res; 2005; 31 Suppl():1-5. PubMed ID: 16444905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of loracarbef in the treatment of pneumonia.
    Hyslop DL
    Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.